P. Souverein

First name
P.
Middle name
C.
Last name
Souverein
van Hulten, V. ., Souverein, P. C., Starup-Linde, J. ., Viggers, R. ., Klungel, O. H., Vestergaard, P. ., … Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes Obes Metab. http://doi.org/10.1111/dom.15884
Eroglu, T. E., Coronel, R. ., & Souverein, P. C. (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvae022
Lalmohamed, A. ., Venekamp, R. P., Bolhuis, A. ., Souverein, P. C., van de Wijgert, J. ., Gulliford, M. C., & Hay, A. D. (2024). Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study. J Infect, 88, 106135. http://doi.org/10.1016/j.jinf.2024.106135
Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J. P., & Vestergaard, P. . (2023). Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study. Bone, 180, 116997. http://doi.org/10.1016/j.bone.2023.116997
Schene, M. R., Wyers, C. E., Driessen, A. M. H., Souverein, P. C., Gemmeke, M. ., van den Bergh, J. P., & Willems, H. C. (2023). Imminent fall risk after fracture. Age Ageing, 52. http://doi.org/10.1093/ageing/afad201
van Hulten, V. ., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R. ., Klungel, O. H., … van den Bergh, J. P. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obes Metab. http://doi.org/10.1111/dom.15220
Gulikers, J. L., van Veelen, A. J., Driessen, J. H. M., Souverein, P. C., Tjan-Heijnen, V. C. G., Hendriks, L. E. L., … Croes, S. . (2023). Comparison of characteristics of patients with lung cancer in U.K. primary care databases: Clinical Practice Research Datalink Aurum and GOLD. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5637
Hageman, S. H., Petitjean, C. ., Pennells, L. ., Kaptoge, S. ., Pajouheshnia, R. ., Tillmann, T. ., … Dorresteijn, J. A. (2023). Improving 10-year cardiovascular risk prediction in apparently healthy people: flexible addition of risk modifiers on top of SCORE2. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwad187
Hunt, N. B., Pajouheshnia, R. ., Salih, A. ., van Doorn, S. ., Souverein, P. C., Bazelier, M. T., … Gardarsdottir, H. . (2023). Prescribing of Low-dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in the United Kingdom and the Netherlands. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15708
Sarodnik, C. ., Rasmussen, N. H., Bours, S. P. G., Schaper, N. C., Vestergaard, P. ., Souverein, P. C., … van den Bergh, J. P. W. (2022). The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus. Bone Rep, 17, 101614. http://doi.org/10.1016/j.bonr.2022.101614